# AMPLATZER PFO Occluder Post Approval Study

> **NCT03309332** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 1214 (actual)

## Conditions studied

- Stroke
- Patent Foramen Ovale

## Interventions

- **DEVICE:** AMPLATZER™ PFO Occluder

## Key facts

- **NCT ID:** NCT03309332
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-31
- **Primary completion:** 2030-02-05
- **Final completion:** 2030-02-05
- **Target enrollment:** 1214 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03309332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03309332, "AMPLATZER PFO Occluder Post Approval Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03309332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*